$DXC

DXC Technology stock rises on ElevenLabs partnership, funding By Investing.com

DXC Technology shares rose about 4.5% after the company announced a strategic partnership with ElevenLabs and participation in ElevenLabs’ $500 million Series D funding, valuing ElevenLabs at about $11 billion. The deal aims to integrate ElevenLabs’ voice AI into DXC operations and customer solutions, including service desk and multilingual voice interfaces.

Original reporting
Published Jul 28, 2026, 6:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 6:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefTechnology
Primary signal
$DXC
Bullish
medium confidence
Mentioned
$DXC
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$DXCBullishMed
01

Why it matters

The disclosed catalyst is a new partnership plus participation in a large funding round, which can drive sentiment and expectations for DXC’s AI go-to-market execution.

02

Market read

DXC’s stock reaction is tied to AI partnership momentum and perceived acceleration of voice AI deployment in enterprise workflows.

03

What to watch

Valuation of ElevenLabs and DXC’s participation do not necessarily translate into DXC earnings; traders may need follow-up disclosures on commercialization, timelines, and customer adoption metrics.

Relevance 7/10Novelty 6/10Timing: Tuesday session, immediately after the partnership and Series D funding announcement.

Background

DXC is positioning its transformation around AI, and the partnership targets voice AI integration across enterprise operations and customer solutions.

Company-level read

Ticker impact

$DXCBullishMedium confidence
Context

DXC shares rose 4.5% after announcing a strategic partnership with ElevenLabs and participation in its $500M Series D funding round.

Expected impact

Likely supports continued upside bias while traders price AI partnership momentum; follow-through depends on disclosed commercial traction.

Evidence & confidence

The article provides a same-day catalyst (partnership plus Series D participation) and a valuation figure, but no revenue, margin, or contract value for DXC.

Market effects

Reinforces the enterprise IT services theme of embedding voice AI into customer service and service desk workflows.

No specific regional impact beyond broad Nasdaq/Dow context mentioned in the opening line.

Supports global AI software and enterprise services demand narrative, but without geographic or regulatory specifics.

Counterpoint

The partnership is strategic and product-focused, but the article lacks contract size or near-term revenue impact, so the move could fade if investors demand financial detail.

Key entities

  • DXC Technology

    Announced a strategic partnership with ElevenLabs and participated in its $500 million Series D funding round.

  • ElevenLabs

    Voice AI provider whose technology will be integrated into DXC’s operations and customer solutions.

Related articles

$DXCMedAI 8/10

DXC (DXC) Q1 2027 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Roger Sachs President and Chief Executive Officer - Raul J. Fernandez Chief Financial Officer - Robert F. Del Bene TAKEAWAYS Total Revenue -- $3 billion, representing a 6.7% organic decline year over year. Adjusted EBIT Margin -- 5.0%, a decrease of 180 basis points year over year reflecting the anticipated revenue profile and seasonal factors.

$DXCMedAI 8/10

DXC’s (NYSE:DXC) Q2 CY2026 Earnings Results: Non

IT services provider DXC Technology (NYSE: DXC) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 5.1% year on year to $3.00 billion. On the other hand, next quarter’s revenue guidance of $2.99 billion was less impressive, coming in 1.5% below analysts’ estimates. Its non-GAAP profit of $0.40 per share was 11.3% below analysts’ consensus estimates. Is now the time to buy DXC? Find out by accessing our full research report, it’s free.

$DXCMedAI 9/10

DXC Technology Co (DXC): Results of Operations and Financial Condition

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 dxcfy27q1pressrelease.htm EX-99.1 Document Exhibit 99.1 DXC Technology Reports First Quarter Fiscal Year 2027 Results • Total revenue for Q1 FY27 of $3.00 billion, down 5.1% YoY, down 6.7% on an organic basis (1) • Q1 FY27 Bookings of $3.0 billion, up 5% YoY with a book

$DXCMed

Why is DXC Technology stock rallying today? By Investing.com

DXC Technology shares rose about 4.3% after the company said it partnered with ElevenLabs and participated in ElevenLabs’ $500 million Series D, valuing the AI firm at about $11 billion, according to DXC’s July 28, 2026 press release. The collaboration targets voice AI for service desk, training, and customer service. DXC’s Q1 FY2027 earnings are due July 30.

$DXCMed

DXC launches Private Cloud+ for regulated workloads

DXC Technology launched DXC Private Cloud+, a hybrid private cloud platform for regulated workloads in enterprises and government agencies. It runs on Dell infrastructure and is orchestrated via DXC OASIS, with options for multi-tenant consumption, single-tenant dedicated, and a government edition. DXC targets sectors like financial services, healthcare, manufacturing and public sector; service is generally available.